Inhibiting the LPS-induced NF-κB pathway allows Kaempferia to prevent keratinocytes and macrophages from producing the pro-inflammatory factors TNF-α, IL-1, IL-6, IL-17, IL-22, and IL-23, indicating that this plant may be a promising candidate for the creation of anti-psoriasis medications [55]. This evidence concerns the gene IL17A and psoriasis.